Failure to find C1q-binding material and anti-IgG antibodies in ankylosing spondylitis.

AUTOR(ES)

Duquesnoy, B

RESUMO

C1q-binding immune complexes (C1C), anti-IgG antibodies (anti-IgG Ab), and complement levels were investigated in the serum of 37 patients with ankylosing spondylitis (AS). In all these studies the mean levels observed in patients with AS were similar to those in 31 normal subjects. Moreover, no significative difference in either CIC or anti-IgG Ab levels was observed when the patients were classified in different clinical forms according to the localisation (peripheral and central) or to the gravity (mild and severe) of the AS. In a parallel study increased CIC and anti-IgG Ab levels were found in most of the 81 patients with seropositive or seronegative rheumatoid arthritis.

Documentos Relacionados

• IgG anti-IgG antibodies in rheumatoid arthritis and certain other conditions.
• Serum Neutralization Anti-IgG Test for Psittacosis
• Serum IgG, IgM, and IgA levels in ankylosing spondylitis.
• Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q.
• Quantitative immunology of immune hemolytic anemia: I. The fixation of C1 by autoimmune antibody and heterologous anti-IgG antibody